- Home
- MOGU vs BCAB Comparison
MOGU vs BCAB Comparison
Compare MOGU & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- BCAB
- Stock Information
- Founded
- MOGU 2011
- BCAB 2007
- Country
- MOGU China
- BCAB United States
- Employees
- MOGU N/A
- BCAB N/A
- Industry
- MOGU Business Services
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- MOGU Consumer Discretionary
- BCAB Health Care
- Exchange
- MOGU Nasdaq
- BCAB Nasdaq
- Market Cap
- MOGU 19.8M
- BCAB 21.6M
- IPO Year
- MOGU 2018
- BCAB 2020
- Fundamental
- Price
- MOGU $2.49
- BCAB $0.54
- Analyst Decision
- MOGU
- BCAB Hold
- Analyst Count
- MOGU 0
- BCAB 3
- Target Price
- MOGU N/A
- BCAB $1.00
- AVG Volume (30 Days)
- MOGU 5.4K
- BCAB 665.1K
- Earning Date
- MOGU 07-21-2025
- BCAB 11-06-2025
- Dividend Yield
- MOGU N/A
- BCAB N/A
- EPS Growth
- MOGU N/A
- BCAB N/A
- EPS
- MOGU N/A
- BCAB N/A
- Revenue
- MOGU $19,462,964.00
- BCAB $11,000,000.00
- Revenue This Year
- MOGU N/A
- BCAB N/A
- Revenue Next Year
- MOGU N/A
- BCAB N/A
- P/E Ratio
- MOGU N/A
- BCAB N/A
- Revenue Growth
- MOGU N/A
- BCAB N/A
- 52 Week Low
- MOGU $1.83
- BCAB $0.24
- 52 Week High
- MOGU $3.14
- BCAB $2.53
- Technical
- Relative Strength Index (RSI)
- MOGU 61.53
- BCAB 72.68
- Support Level
- MOGU $2.11
- BCAB $0.44
- Resistance Level
- MOGU $2.51
- BCAB $0.46
- Average True Range (ATR)
- MOGU 0.14
- BCAB 0.04
- MACD
- MOGU 0.03
- BCAB 0.02
- Stochastic Oscillator
- MOGU 69.64
- BCAB 96.87
About MOGU MOGU Inc. (each representing 25)
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.